12 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Main Reason for Testing for COVID-19Primary· Baseline
Those that used a test from a kit were asked to provide the reason why they were doing a test. The possible answers are: "I wanted to be sure I/my child did not have COVID-19 before being around others", "I/my child had COVID-19 like symptoms", "I/my child was in close contact with someone who might have COVID-19", "I/my child was in close contact with someone who tested positive for COVID-19", "Someone in my household might have COVID-19", "Someone in my household tested positive for COVID-19", "Other"
I wanted to be sure I/my child did not have COVID-19 before being around others
Group
Value
95% CI
Behavioral Questionnaires
1632
I/my child had COVID-19 like symptoms
Group
Value
95% CI
Behavioral Questionnaires
493
I/my child was in close contact with someone who might have COVID-19
Group
Value
95% CI
Behavioral Questionnaires
238
I/my child was in close contact with someone who tested positive for COVID-19
Group
Value
95% CI
Behavioral Questionnaires
343
Someone in my household might have COVID-19
Group
Value
95% CI
Behavioral Questionnaires
118
Someone in my household tested positive for COVID-19
Group
Value
95% CI
Behavioral Questionnaires
152
Other
Group
Value
95% CI
Behavioral Questionnaires
209
Number of Positive COVID-19 Test ResultsPrimary· Baseline
Group
Value
95% CI
Behavioral Questionnaires
269
Number of Participants Who Responded That They Have Received a COVID VaccinePrimary· Baseline
Group
Value
95% CI
Behavioral Questionnaires
850
Number of Participants Who Indicated That They Have Access to Necessary Personal Protective Equipment in Work PlaceSecondary· Baseline
Group
Value
95% CI
Behavioral Questionnaires
475
Number of Participants Who Indicated They Have Tested Positive for COVID in Their LifetimeSecondary· Baseline
Group
Value
95% CI
Behavioral Questionnaires
237
Number of Participants Who Report Knowing Where to Get COVID-19 Tests in the CommunitySecondary· Baseline
Group
Value
95% CI
Behavioral Questionnaires
757
Number of Participants Who Report COVID Symptoms During Previous WeekSecondary· Baseline
Group
Value
95% CI
Behavioral Questionnaires
627
Likelihood of Future COVID-19 VaccinationSecondary· Baseline
Number of participants with front door survey entries indicating various levels of the likelihood the responder will get vaccinated in the future. Available options: "Very likely", "Somewhat likely", "Not very likely", "Not at all likely", and "Prefer not to answer".
Group
Value
95% CI
Behavioral Questionnaires
119
Behavioral Questionnaires
140
Behavioral Questionnaires
59
Behavioral Questionnaires
92
Reasons for Not Getting a COVID-19 VaccineSecondary· Baseline
Number of participants indicating various reasons for why they have not received a COVID-19 vaccine on the baseline survey. Available options: "I'm allergic to vaccines", "I don't like needles", "I'm not concerned about getting really sick from COVID-19", "I'm concerned about side effects from the vaccines", "I don't think vaccines work very well", "I don't trust that the vaccines will be safe", "I don't believe the COVID-19 pandemic is as bad as some people say it is", "I don't want to pay for it", and "I don't know enough about how well a COVID-19 vaccine works".
I'm allergic to vaccines
Group
Value
95% CI
Behavioral Questionnaires
5
I don't like needles
Group
Value
95% CI
Behavioral Questionnaires
22
I'm not concerned about getting really sick from COVID-19
Group
Value
95% CI
Behavioral Questionnaires
3
I'm concerned about side effects from the vaccines
Group
Value
95% CI
Behavioral Questionnaires
47
I don't think vaccines work very well
Group
Value
95% CI
Behavioral Questionnaires
7
I don't trust that the vaccines will be safe
Group
Value
95% CI
Behavioral Questionnaires
34
I don't believe the COVID-19 pandemic is as bad as some people say it is
Group
Value
95% CI
Behavioral Questionnaires
4
I don't want to pay for it
Group
Value
95% CI
Behavioral Questionnaires
3
Reasons for Getting a COVID-19 VaccineSecondary· Baseline
Number of participants indicating various reasons for why they have received a COVID-19 vaccine on the baseline survey. Available options: "I want to keep my family safe", "I want to keep my community safe", "I want to keep myself safe", "I have a chronic health problem, like asthma or diabetes", "My doctor told me to get a COVID-19 vaccine", "I don't want to get really sick from COVID-19", "I want to feel safe around other people", "I believe life won't go back to normal until most people get a COVID-19 vaccine", "Required by my school or workplace", and "Required for travel".
I want to keep my family safe
Group
Value
95% CI
Behavioral Questionnaires
712
I want to keep my community safe
Group
Value
95% CI
Behavioral Questionnaires
477
I want to keep myself safe
Group
Value
95% CI
Behavioral Questionnaires
557
I have a chronic health problem, like asthma or diabetes
Group
Value
95% CI
Behavioral Questionnaires
135
My doctor told me to get a COVID-19 vaccine
Group
Value
95% CI
Behavioral Questionnaires
86
I don't want to get really sick from COVID-19
Group
Value
95% CI
Behavioral Questionnaires
378
I want to feel safe around other people
Group
Value
95% CI
Behavioral Questionnaires
404
I believe life won't go back to normal until most people get a COVID-19 vaccine
Group
Value
95% CI
Behavioral Questionnaires
313
Perspective on Easiest Way to Obtain Free Oral COVID-19 MedicationsSecondary· Baseline
Number of front door survey entries indicating various ways in which participants would find it easy to get free COVID-19 oral medications. Available options: "An urgent care center". "A doctor's or other health professional's office", "A mobile health unit", "A drug store / pharmacy", "A grocery store", "A community center", "A place of worship", "A community park", "A neighborhood school", or "other". More than one answer can be selected by an individual participant.
An urgent care center
Group
Value
95% CI
Behavioral Questionnaires
503
A doctor's or other health professional's office
Group
Value
95% CI
Behavioral Questionnaires
526
A mobile health unit
Group
Value
95% CI
Behavioral Questionnaires
189
A drug store / pharmacy
Group
Value
95% CI
Behavioral Questionnaires
1225
A grocery store
Group
Value
95% CI
Behavioral Questionnaires
209
A community center
Group
Value
95% CI
Behavioral Questionnaires
87
A place of worship
Group
Value
95% CI
Behavioral Questionnaires
38
A community park
Group
Value
95% CI
Behavioral Questionnaires
50
Method Used to Test for COVID-19Secondary· Baseline
Number of participants indicating the method used to test for COVID-19 on the baseline survey. Available options: "Nasal swab", "Throat swab", "Blood sample", and "Saliva".
Group
Value
95% CI
Behavioral Questionnaires
783
Behavioral Questionnaires
15
Behavioral Questionnaires
4
Behavioral Questionnaires
17
Sponsor's own description
Observational, study that distributes rapid at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communities.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT04949243 — Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing
· completed
Other recruiting trials for COVID-19
Currently open trials in the same condition.
NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults
· Phase 1
· active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
· Phase 3
· active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
· Phase 1
· recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults
· Phase 2
· recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A
· Phase 3
· active not recruiting
Other Duke University trials
Trials by the same sponsor.
NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation
· NA
· not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment
· NA
· not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
· Phase 1
· not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study
· NA
· not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 6 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05212883.